Andreas Strungmann is a German pharmacist and co-founder of Hexal AG, the generic drug company. As per Forbes estimates, his net worth is $3.4 billion. He is among the top-25 richest persons in Germany and is ranked #395 in the world. The University of Buffalo graduate holds a degree in medicine but he has mainly acquired his net worth from Hexal AG.
Andreas started his medical practice in Africa and in 1986 he, along with his twin brother, founded Hexal AG. But in 2000s they sold the company and also their 2/3rd stake (68%) in Eon Labs of US to pharmaceutical giant, Novartis, thereby making Sandoz the biggest generic drug company. The sale to Novartis, as per reports, was worth $7.5 billion. Since then the two brothers have been investing primarily in the German biotech sector through Santo Hodling. This company acquired a major chunk of the anti-infective division from Bayer.
Andreas and Thomas Strungmann also established a research center for neuroscience in Frankfurt that has been named after Ernst Strungmann, their father. Andreas is a keen golfer and also has an avid interest in skiing and sailing. He is now in his sixties and lives with his wife in Tegernsee in Germany. He has two children.
Read also : The Billionaires of Germany